{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:56:51Z","timestamp":1783076211125,"version":"3.54.6"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Henan Medical Science and Technology Research","award":["20180209590"],"award-info":[{"award-number":["20180209590"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.intimp.2020.106372","type":"journal-article","created":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T00:08:56Z","timestamp":1584144536000},"page":"106372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Alogliptin inhibits IL-1\u03b2-induced inflammatory response in fibroblast-like synoviocytes"],"prefix":"10.1016","volume":"83","author":[{"given":"Qi","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuqin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2020.106372_b0005","doi-asserted-by":"crossref","first-page":"e001469","DOI":"10.1161\/JAHA.114.001469","article-title":"Dipeptidyl-peptidase-4 inhibitor, alogliptin, attenuates arterial inflammation and neointimal formation after injury in low-density lipoprotein (LDL) receptor-deficient mice","volume":"4","author":"Akita","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.intimp.2020.106372_b0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s41927-017-0001-8","article-title":"Cytokines in the pathogenesis of rheumatoid arthritis: new players and therapeutic targets","volume":"1","author":"Alunno","year":"2017","journal-title":"BMC Rheumatol."},{"issue":"14","key":"10.1016\/j.intimp.2020.106372_b0015","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.2174\/13816128113199990474","article-title":"Dipeptidyl-peptidase 4 inhibition: linking metabolic control to cardiovascular protection","volume":"20","author":"Avogaro","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.intimp.2020.106372_b0020","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","article-title":"Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis","volume":"233","author":"Bartok","year":"2010","journal-title":"Immunol. Rev."},{"issue":"4","key":"10.1016\/j.intimp.2020.106372_b0025","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.numecd.2016.03.002","article-title":"DPP-4 inhibitors and cardiovascular disease in type 2 diabetes mellitus. Expectations, observations and perspectives","volume":"26","author":"Bonora","year":"2016","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.intimp.2020.106372_b0030","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2741\/1817","article-title":"Matrix metalloproteinases: role in arthritis","volume":"11","author":"Burrage","year":"2006","journal-title":"Front. Biosci."},{"issue":"4","key":"10.1016\/j.intimp.2020.106372_b0040","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/14728214.2016.1257608","article-title":"An update on DPP-4 inhibitors in the management of type 2 diabetes","volume":"21","author":"Cahn","year":"2016","journal-title":"Expert. Opin. Emerg. Drugs."},{"issue":"3","key":"10.1016\/j.intimp.2020.106372_b0045","first-page":"347","article-title":"One year in review 2019: pathogenesis of rheumatoid arthritis","volume":"37","author":"Croia","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2020.106372_b0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.berh.2017.08.003","article-title":"Genetic and environmental risk factors for rheumatoid arthritis","volume":"31","author":"Deane","year":"2017","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"2","key":"10.1016\/j.intimp.2020.106372_b0055","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","article-title":"Immunopathogenesis of rheumatoid arthritis","volume":"46","author":"Firestein","year":"2017","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.intimp.2020.106372_b0060","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/rheumatology\/ket414","article-title":"Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets","volume":"53","author":"Furst","year":"2014","journal-title":"Rheumatol. (Oxford)"},{"key":"10.1016\/j.intimp.2020.106372_b0065","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2147\/JIR.S140188","article-title":"Mechanisms of NF-\u03baB p65 and strategies for therapeutic manipulation","volume":"11","author":"Giridharan","year":"2018","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.intimp.2020.106372_b0070","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.biopha.2018.10.064","article-title":"The neurovascular protective effect of alogliptin in murine MCAO model and brain endothelial cells","volume":"109","author":"Hao","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.intimp.2020.106372_b0075","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/08830185.2016.1269175","article-title":"Fibroblast-like synoviocytes-dependent effector molecules as a critical mediator for rheumatoid arthritis: Current status and future directions","volume":"36","author":"Ganesan","year":"2017","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.intimp.2020.106372_b0080","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.biopha.2018.10.052","article-title":"DPP-4 inhibitor impedes lipopolysaccharide-induced osteoclast formation and bone resorption in vivo","volume":"109","author":"Shida","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.intimp.2020.106372_b0085","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/carcin\/bgz009","article-title":"The CD26\/DPP4-inhibitor vildagliptin suppresses lung cancer growth via macrophage-mediated NK cell activity","volume":"40","author":"Jang","year":"2019","journal-title":"Carcinogenesis"},{"issue":"suppl_3","key":"10.1016\/j.intimp.2020.106372_b0090","doi-asserted-by":"crossref","first-page":"iii2","DOI":"10.1093\/rheumatology\/keh201","article-title":"The role of interleukin-1 in the pathogenesis of rheumatoid arthritis","volume":"43","author":"Kay","year":"2004","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.intimp.2020.106372_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cei.12781","article-title":"Cut to the chase: a review of CD26\/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system","volume":"185","author":"Klemann","year":"2016","journal-title":"Clin. Exp. Immunol."},{"issue":"Suppl1","key":"10.1016\/j.intimp.2020.106372_b0100","first-page":"S27","article-title":"Effect of taurine chloramine on the production of matrix metalloproteinases (MMPs) in adiponectin- or IL-1beta-stimulated fibroblast-like synoviocytes","volume":"17","author":"Kim","year":"2007","journal-title":"Biomed Sci."},{"key":"10.1016\/j.intimp.2020.106372_b0105","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/1381612820666140825122036","article-title":"Role of synovial fbroblasts in rheumatoid arthritis","volume":"21","author":"Lefevre","year":"2015","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.intimp.2020.106372_b0115","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180541","article-title":"SIRT1 inhibits rheumatoid arthritis fibroblast-like synoviocyte aggressiveness and inflammatory response via suppressing NF-\u03baB pathway","volume":"38","author":"Li","year":"2018","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.intimp.2020.106372_b0120","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.intimp.2017.12.006","article-title":"Oxymatrine prevents synovial inflammation and migration via blocking NF-\u03baB activation in rheumatoid fibroblast-like synoviocytes","volume":"55","author":"Liang","year":"2018","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2020.106372_b0125","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.intimp.2011.11.008","article-title":"Saucerneol F, a new lignan, inhibits iNOS expression via MAPKs, NF-\u03baB and AP-1 inactivation in LPS-induced RAW264.7 cells","volume":"12","author":"Lu","year":"2012","journal-title":"Int. Immunopharmacol."},{"issue":"9","key":"10.1016\/j.intimp.2020.106372_b0130","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1210\/jc.2012-1544","article-title":"Sitagliptin exerts an antinflammatory action","volume":"97","author":"Makdissi","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.intimp.2020.106372_b0135","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1046\/j.1462-5822.2001.00148.x","article-title":"NF-kappaB and the MAP kinases\/AP-1 pathways are both involved in interleukin-6 and interleukin-8 expression in fibroblast-like synoviocytes stimulated by protein I\/II, a modulin from oral streptococci","volume":"3","author":"Neff","year":"2001","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.intimp.2020.106372_b0140","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1475-2840-12-8","article-title":"Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in non-diabetic subjects: a preliminary report","volume":"12","author":"Noda","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.intimp.2020.106372_b0145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13075-015-0527-3","article-title":"Non-canonical NF-\u03baB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde?","volume":"17","author":"Noort","year":"2015","journal-title":"Arthritis. Res. Ther."},{"issue":"4","key":"10.1016\/j.intimp.2020.106372_b0150","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2174\/187153006779025685","article-title":"NF-kappaB and rheumatic diseases","volume":"6","author":"Okamoto","year":"2006","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"issue":"8","key":"10.1016\/j.intimp.2020.106372_b0155","first-page":"1440","article-title":"Effect of nuclear factor-kappaB inhibition on rheumatoid fibroblast-like synoviocytes and collagen induced arthritis","volume":"32","author":"Okazaki","year":"2005","journal-title":"J. Rheumatol."},{"issue":"20","key":"10.1016\/j.intimp.2020.106372_b0160","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1007\/s00018-013-1286-4","article-title":"Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences","volume":"70","author":"Pillay","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.intimp.2020.106372_b0165","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/BOR.0000000000000470","article-title":"What are the dominant cytokines in early rheumatoid arthritis?","volume":"30","author":"Ridgley","year":"2018","journal-title":"Curr. Opin. Rheumatol."},{"issue":"2","key":"10.1016\/j.intimp.2020.106372_b0170","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12192-017-0839-0","article-title":"Modulation of Alzheimer's amyloid \u03b2 peptide oligomerization and toxicity by extracellular Hsp70","volume":"23","author":"Rivera","year":"2018","journal-title":"Cell Stress Chaperones."},{"key":"10.1016\/j.intimp.2020.106372_b0175","first-page":"5407","article-title":"Molecular targets in arthritis and recent trends in nanotherapy","volume":"10","author":"Roy","year":"2015","journal-title":"Int. J. Nanomed."},{"issue":"3","key":"10.1016\/j.intimp.2020.106372_b0180","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2174\/1574887113666180314102651","article-title":"The Emerging Role of IL-1 Inhibition in Patients Affected by Rheumatoid Arthritis and Diabetes","volume":"13","author":"Ruscitti","year":"2018","journal-title":"Rev. Recent. Clin. Trials."},{"issue":"9","key":"10.1016\/j.intimp.2020.106372_b0185","doi-asserted-by":"crossref","first-page":"e1002901","DOI":"10.1371\/journal.pmed.1002901","article-title":"Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial","volume":"16","author":"Ruscitti","year":"2019","journal-title":"PLoS Med."},{"key":"10.1016\/j.intimp.2020.106372_b0190","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.lfs.2018.10.069","article-title":"Alogliptin abates memory injuries of hepatic encephalopathy induced by acute paracetamol intoxication via switching-off autophagy-related apoptosis","volume":"215","author":"Saad","year":"2018","journal-title":"Life Sci."},{"issue":"36","key":"10.1016\/j.intimp.2020.106372_b0195","doi-asserted-by":"crossref","first-page":"11389","DOI":"10.1073\/pnas.1513047112","article-title":"Mitochondrial calcium overload is a key determinant in heart failure","volume":"112","author":"Santulli","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1\u20133","key":"10.1016\/j.intimp.2020.106372_b0200","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.vph.2011.03.001","article-title":"Acute DPP-4 inhibition modulates vascular tone through GLP-1 independent pathways","volume":"55","author":"Shah","year":"2011","journal-title":"Vasc. Pharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2020.106372_b0205","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/rheumatology\/kem298","article-title":"Signalling, inflammation and arthritis: NF-kappaB and its relevance to arthritis and inflammation","volume":"47","author":"Simmonds","year":"2008","journal-title":"Rheumatol. (Oxford)"},{"issue":"11","key":"10.1016\/j.intimp.2020.106372_b0210","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1002\/art.24887","article-title":"Gadd45beta deficiency in rheumatoid arthritis: enhanced synovitis through JNK signaling","volume":"60","author":"Svensson","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2020.106372_b0215","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/FJC.0b013e31821e5626","article-title":"DPP-4 (CD26) inhibitor alogliptin inhibits atherosclerosis in diabetic apolipoprotein E-deficient mice","volume":"58","author":"Ta","year":"2011","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.intimp.2020.106372_b0220","doi-asserted-by":"crossref","first-page":"561459","DOI":"10.1155\/2014\/561459","article-title":"The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis","volume":"2014","author":"Wojdasiewicz","year":"2014","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.intimp.2020.106372_b0225","doi-asserted-by":"crossref","first-page":"11427","DOI":"10.1038\/srep11427","article-title":"Mitochondrial oxidative stress promotes atrial fibrillation","volume":"5","author":"Xie","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2020.106372_b0230","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.brainres.2013.04.015","article-title":"Alogliptin, a dipeptidylpeptidase-4 inhibitor, for patients with diabetes mellitus type 2, induces tolerance to focal cerebral ischemia in non-diabetic, normal mice","volume":"1517","author":"Yang","year":"2013","journal-title":"Brain Res."},{"issue":"10","key":"10.1016\/j.intimp.2020.106372_b0235","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3390\/cells7100161","article-title":"Pathogenic Role of Immune Cells in Rheumatoid Arthritis: Implications in Clinical Treatment and Biomarker Development","volume":"7","author":"Yap","year":"2018","journal-title":"Cells."},{"issue":"1","key":"10.1016\/j.intimp.2020.106372_b0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4196\/kjpp.2018.22.1.1","article-title":"Role of inflammasomes in inflammatory autoimmune rheumatic diseases","volume":"22","author":"Yi","year":"2018","journal-title":"Korean J. Physiol. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2020.106372_b0245","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.bbrc.2019.02.065","article-title":"Alogliptin alleviates liver fibrosis via suppression of activated hepatic stellate cell","volume":"511","author":"Zhang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.intimp.2020.106372_b0250","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1463-1326.2010.01354.x","article-title":"Effects of chronic administration of alogliptin on the development of diabetes and \u03b2-cell function in high fat diet\/streptozotocin diabetic mice","volume":"13","author":"Zhang","year":"2011","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"10.1016\/j.intimp.2020.106372_b0255","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12933-018-0803-z","article-title":"Alogliptin prevents diastolic dysfunction and preserves left ventricular mitochondrial function in diabetic rabbits","volume":"17","author":"Zhang","year":"2018","journal-title":"Cardiovasc Diabetol."},{"issue":"5","key":"10.1016\/j.intimp.2020.106372_b0260","doi-asserted-by":"crossref","first-page":"e005945","DOI":"10.1161\/JAHA.117.005945","article-title":"Alogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits","volume":"6","author":"Zhang","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.intimp.2020.106372_b0265","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.intimp.2018.11.007","article-title":"Protective effects of alogliptin against TNF-\u03b1-induced degradation of extracellular matrix in human chondrocytes","volume":"68","author":"Zhang","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2020.106372_b0270","doi-asserted-by":"crossref","first-page":"e12883","DOI":"10.1111\/acel.12883","article-title":"Alogliptin improves survival and health of mice on a high-fat diet","volume":"18","author":"Zhu","year":"2019","journal-title":"Aging Cell"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919328747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919328747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:17:39Z","timestamp":1761585459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576919328747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":52,"alternative-id":["S1567576919328747"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106372","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alogliptin inhibits IL-1\u03b2-induced inflammatory response in fibroblast-like synoviocytes","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106372","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106372"}}